Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Lorusso

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2015
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trialA Passardi, O Nanni, D Tassinari, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLCM De Lena, R Ramlau, O Hansen, et al.
Medical Oncology (Northwood, London, England)|December 6, 2013
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practiceS Barni, V Lorusso, M Giordano, et al.
British Journal of Cancer|February 20, 2003
Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancerV Lorusso, E Crucitta, N Silvestris, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trialG Frasci, V Lorusso, N Panza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancerV Lorusso, F Carpagnano, G Frasci, et al.
British Journal of Cancer|June 27, 2002
Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patientsP Comella, R Casaretti, E Crucitta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclinesA Berruti, P Sperone, A Bottini, et al.
British Journal of Cancer|May 22, 2008
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II studyV Adamo, V Lorusso, R Rossello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2014
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapyM Aapro, H Rugo, G Rossi, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2015
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trialA Passardi, O Nanni, D Tassinari, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLCM De Lena, R Ramlau, O Hansen, et al.
Medical Oncology (Northwood, London, England)|December 6, 2013
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practiceS Barni, V Lorusso, M Giordano, et al.
British Journal of Cancer|February 20, 2003
Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancerV Lorusso, E Crucitta, N Silvestris, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trialG Frasci, V Lorusso, N Panza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancerV Lorusso, F Carpagnano, G Frasci, et al.
British Journal of Cancer|June 27, 2002
Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patientsP Comella, R Casaretti, E Crucitta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclinesA Berruti, P Sperone, A Bottini, et al.
British Journal of Cancer|May 22, 2008
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II studyV Adamo, V Lorusso, R Rossello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2014
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapyM Aapro, H Rugo, G Rossi, et al.
Pageof 18